These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21732353)
1. Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts. Kawamata A; Inoue A; Miyajima D; Hemmi H; Mashima R; Hayata T; Ezura Y; Amagasa T; Yamanashi Y; Noda M J Cell Physiol; 2011 Dec; 226(12):3087-93. PubMed ID: 21732353 [TBL] [Abstract][Full Text] [Related]
2. Dok-3 and Dok-1/-2 adaptors play distinctive roles in cell fusion and proliferation during osteoclastogenesis and cooperatively protect mice from osteopenia. Kajikawa S; Taguchi Y; Hayata T; Ezura Y; Ueta R; Arimura S; Inoue JI; Noda M; Yamanashi Y Biochem Biophys Res Commun; 2018 Apr; 498(4):967-974. PubMed ID: 29548825 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat. Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756 [TBL] [Abstract][Full Text] [Related]
5. Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice. Xiao Z; Awad HA; Liu S; Mahlios J; Zhang S; Guilak F; Mayo MS; Quarles LD Dev Biol; 2005 Jul; 283(2):345-56. PubMed ID: 15936013 [TBL] [Abstract][Full Text] [Related]
6. Rho-GEF trio regulates osteoclast differentiation and function by Rac1/Cdc42. Gu J; Yang Z; Yuan L; Guo S; Wang D; Zhao N; Meng L; Liu H; Chen W; Ma J Exp Cell Res; 2020 Nov; 396(1):112265. PubMed ID: 32898553 [TBL] [Abstract][Full Text] [Related]
7. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. Koyama H; Nakade O; Takada Y; Kaku T; Lau KH J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835 [TBL] [Abstract][Full Text] [Related]
8. CD109 deficiency induces osteopenia with an osteoporosis-like phenotype in vivo. Mii S; Hoshino A; Enomoto A; Murakumo Y; Ito M; Yamaguchi A; Takahashi M Genes Cells; 2018 Jul; 23(7):590-598. PubMed ID: 29767469 [TBL] [Abstract][Full Text] [Related]
9. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone. Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596 [TBL] [Abstract][Full Text] [Related]
10. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling. Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989 [TBL] [Abstract][Full Text] [Related]
11. Myeloid Lineage Ablation of Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866 [TBL] [Abstract][Full Text] [Related]
13. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. Ikeda F; Nishimura R; Matsubara T; Hata K; Reddy SV; Yoneda T J Immunol; 2006 Aug; 177(4):2384-90. PubMed ID: 16888000 [TBL] [Abstract][Full Text] [Related]
14. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. Nakajima A; Sanjay A; Chiusaroli R; Adapala NS; Neff L; Itzsteink C; Horne WC; Baron R J Bone Miner Res; 2009 Jul; 24(7):1162-72. PubMed ID: 19257814 [TBL] [Abstract][Full Text] [Related]
15. Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma. Mashima R; Honda K; Yang Y; Morita Y; Inoue A; Arimura S; Nishina H; Ema H; Nakauchi H; Seed B; Oda H; Yamanashi Y Lab Invest; 2010 Sep; 90(9):1357-64. PubMed ID: 20548287 [TBL] [Abstract][Full Text] [Related]
16. Climbing exercise increases bone mass and trabecular bone turnover through transient regulation of marrow osteogenic and osteoclastogenic potentials in mice. Mori T; Okimoto N; Sakai A; Okazaki Y; Nakura N; Notomi T; Nakamura T J Bone Miner Res; 2003 Nov; 18(11):2002-9. PubMed ID: 14606513 [TBL] [Abstract][Full Text] [Related]
17. The deficiency of immunoregulatory receptor PD-1 causes mild osteopetrosis. Nagahama K; Aoki K; Nonaka K; Saito H; Takahashi M; Varghese BJ; Shimokawa H; Azuma M; Ohya K; Ohyama K Bone; 2004 Nov; 35(5):1059-68. PubMed ID: 15542030 [TBL] [Abstract][Full Text] [Related]
18. Loss of Dok-1 and Dok-2 in mice causes severe experimental colitis accompanied by reduced expression of IL-17A and IL-22. Waseda M; Arimura S; Shimura E; Nakae S; Yamanashi Y Biochem Biophys Res Commun; 2016 Sep; 478(1):135-142. PubMed ID: 27450811 [TBL] [Abstract][Full Text] [Related]
20. Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation. Sul OJ; Ke K; Kim WK; Kim SH; Lee SC; Kim HJ; Kim SY; Suh JH; Choi HS J Cell Physiol; 2012 Apr; 227(4):1619-27. PubMed ID: 21678414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]